BRIEF published on 07/09/2024 at 15:40, 4 months 15 days ago The Vanguard Group Discloses Stake in Virgin Money UK plc Form 8.3 The Vanguard Group Takeover Code Stake Disclosure Virgin Money UK
BRIEF published on 07/09/2024 at 15:38, 4 months 15 days ago Form 8.3 Disclosure by The Vanguard Group, Inc. on Wood Group (John) plc Securities Disclosure Takeover Code Vanguard Group Wood Group
BRIEF published on 07/09/2024 at 15:36, 4 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Tyman plc Form 8.3 The Vanguard Group Takeover Code Securities Disclosure Tyman PLC
PRESS RELEASE published on 07/09/2024 at 15:35, 4 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Virgin Money UK plc The Vanguard Group, Inc. discloses a 5.77% ownership in Virgin Money UK plc. Form 8.3 filing under Rule 8.3 of the Takeover Code on 09-Jul-2024 Form 8.3 The Vanguard Group Ownership Disclosure Virgin Money UK Plc 5.77%
BRIEF published on 07/09/2024 at 15:34, 4 months 15 days ago The Vanguard Group, Inc. Discloses Position in Tritax EuroBox plc Securities Disclosure Takeover Code Vanguard Tritax EuroBox
PRESS RELEASE published on 07/09/2024 at 15:33, 4 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Wood Group (John) plc The Vanguard Group, Inc. makes a public opening position disclosure on Wood Group (John) plc. Details of interests and short positions revealed The Vanguard Group, Inc. Relevant Securities Short Positions Public Opening Position Disclosure Wood Group (John) PLC
BRIEF published on 07/09/2024 at 15:32, 4 months 15 days ago Vanguard Discloses Position in Spirent Communications plc Form 8.3 Vanguard Group Financial Disclosure Shareholdings Spirent Communications
PRESS RELEASE published on 07/09/2024 at 15:31, 4 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Tyman plc The Vanguard Group, Inc. discloses a 1.57% interest in Tyman plc as of 08 July 2024. Additional disclosures include dealings with Quanex Building Products Corporation Disclosure The Vanguard Group Inc Dealings Interest Tyman PLC
BRIEF published on 07/09/2024 at 15:30, 4 months 15 days ago The Vanguard Group Discloses Position in Smith (DS) plc The Vanguard Group Takeover Code Securities Disclosure Smith (DS) Plc
PRESS RELEASE published on 07/09/2024 at 15:29, 4 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Tritax EuroBox plc The Vanguard Group, Inc. discloses 1.36% stake in Tritax EuroBox plc with 10,992,124 shares. Form 8.3 submission under Takeover Code rules Form 8.3 Vanguard Group Inc. Takeover Code Share Disclosure Tritax EuroBox Plc
Published on 11/25/2024 at 04:00, 2 hours 13 minutes ago Tanzania Safaris Unveils New Luxury Adventure Packages for 2025
Published on 11/22/2024 at 23:55, 2 days 6 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 2 days 6 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 2 days 7 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/24/2024 at 19:16, 10 hours 56 minutes ago EQS-Adhoc: RENK Group AG: Termination of mandate of CEO Susanne Wiegand and appointment of Dr. Alexander Sagel as CEO
Published on 11/24/2024 at 19:07, 11 hours 5 minutes ago EQS-Adhoc: ABO Energy KGaA reduces forecast for the 2024 annual result to EUR 20 to 25 million and confirms market expectation for the 2025 financial year
Published on 11/22/2024 at 18:14, 2 days 11 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 2 days 12 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 06:58, 3 days 23 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 4 days 10 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 4 days 12 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 4 days 12 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024